As of May 26
| -0.24 / -0.79%|
The 6 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 29.00, with a high estimate of 35.00 and a low estimate of 28.00. The median estimate represents a -4.01% decrease from the last price of 30.21.
The current consensus among 7 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.